The following drugs have recently been approved by the FDA. Includes newly approved drugs and new indications for drugs already approved.

 Gemtesa (vibegron) Tablets

Gemtesa (vibegron) is a once-daily beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.  

Ebanga (ansuvimab-zykl) Injection

Ebanga (ansuvimab-zykl) is a monoclonal antibody for the treatment of Zaire ebolavirus (Ebolavirus) infection in adults and children.

Orgovyx (relugolix) Tablets

Orgovyx (relugolix) is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of adult patients with advanced prostate cancer. 

Riabni (rituximab-arrx) Injection

Riabni (rituximab-arrx) is a CD20-directed cytolytic antibody biosimilar to Rituxan indicated for the treatment of adult patients with non-Hodgkin’s Lymphoma (NHL), chronic lymphocytic leukemia (CLL), and granulomatosis with polyangiitis (GPA) (Wegener’s Granulomatosis) and microscopic polyangiitis (MPA).

Submit your Manuscripts online

Source : https://www.interesjournals.org/medicine-medical-sciences.html

Thanks & Regards
Michaelangelo
Editorial Coordinator
Journal of Medicine and Medical Sciences
ISSN: 2141-9477